Vaccine for the novel coronavirus, 2019-nCoV (COVID-19) based on two approaches. The first approach deals with development of a DNA vaccine against the major viral membrane protein responsible for the cell entry of the novel coronavirus, now called COVID-19. The second approach deals with development of a live attenuated recombinant measles virus vectored vaccine against COVID-19.
Acces sibility Controls